Clevudine (also known as L-FMAU) is an antiviral medication used to treat chronic hepatitis B virus (HBV) infection. It is used in combination with other antiviral medications and is taken as a once-daily oral tablet. Clevudine works by inhibiting the replication of the virus in the body, which reduces the amount of virus in the blood, thus improving symptoms and decreasing the risk of complications from the virus.
Clevudine is an antiviral medication used to treat chronic hepatitis B infection. It is a synthetic pyrimidine nucleoside analogue, which means it is a man-made molecule that is similar to a natural substance found in cells called pyrimidine. Clevudine is marketed under the brand names Levovir and Revovir.
Clevudine works by interfering with the replication of the hepatitis B virus (HBV). When taken into the body, clevudine is converted into its active form, clevudine triphosphate. This molecule competes with thymidine triphosphate, a natural building block of DNA, for incorporation into viral DNA. Once incorporated into viral DNA, clevudine triphosphate causes the DNA chain to terminate, preventing the virus from replicating.
Clevudine is typically taken orally once or twice a day for up to 48 weeks. The most common side effects of clevudine are fatigue, nausea, and vomiting. Clevudine can also interact with other medications, so it is important to tell your doctor about all the medications you are taking before starting clevudine.
Clevudine is an effective treatment for chronic hepatitis B infection, but it is not a cure. People who take clevudine need to be monitored by their doctor for liver function and other potential side effects.
It is important to note that clevudine is not approved for the treatment of COVID-19. While there is some ongoing research into the potential use of clevudine for COVID-19, it is too early to say whether it is safe or effective for this purpose.